The challenge for all healthcare organizations lies in the quality and completeness gap of their data. For example, in working with one major regional organization, we were able to increase the quality of their lab data so that 98% of it was usable, compared with only 35% before.
TULSA, Okla. (PRWEB) July 22, 2020
Healthcare data curation and enrichment company Verinovum today announced the launch of its new Data Curation as a Service (DCaaS) solution for payers, providers, healthcare systems, and OEM partners.
Verinovum’s targeted use case modules focus on specific clinical data curation parameters and are custom tailored to provide clients a clear, trusted, comprehensive data curation and enrichment engine required to optimize use case analytics and outcomes. Targeted use cases include chronic care management of conditions such as CHF, COPD, asthma, diabetes, oncology, and others, as well as preventive care efforts such as immunizations, prenatal care, medication management, and more.
“Institutions across the healthcare continuum will get greater benefit out of their disparate data if they approach it from the perspective of targeted use case needs,” says Verinovum CEO Mark McCurry. “Some organizations approach the challenge of disparate data by extracting and dumping data into agnostic groupings. This data then ends up being manually manipulated for a specific use case., which is labor-intensive, rigid, and reactive. Our approach is different; we focus on the highest value data sets within each specific use case, and then curate and enrich them within those parameters to the point of true reliability. This method provides flexibility to meet clients’ top priorities for today, while maintaining flexibility as business, clinical, and legislative stakeholder needs shift over time.”
The importance of these targeted modules arose out of real-world examples derived from Verinovum’s payer, provider, and other healthcare organization clients. For example, if 10% of a payer’s members have diabetes, but curated/enriched A1c lab data only exists on 35% of that population, the payer is missing out on a significant opportunity to enroll two-thirds of its diabetic population into disease management programs that can improve patient outcomes, reduce the risk of acute events, reduce unnecessary hospital admissions and readmissions, and lower downstream healthcare costs. In addition to putting members at risk, the downstream implications on ROI can be significant.
Verinovum’s DCaaS use case modules help to:
- Realize member/patient savings
- Reduce administrative costs and time to acquire clinical data
- Optimize population health programs
- Build a reliable foundation for value-based activities
- Improve quality measures
- Access up-to-the-minute, reliable data at the point of care
- Establish a strong data foundation for population health/analytics tools
“The challenge for all healthcare organizations lies in the quality and completeness gap of their data. For example, in working with one major regional organization, we were able to increase the quality of their lab data so that 98% of it was usable, compared with only 35% before,” says Mike Noshay, Verinovum’s Chief Strategy & Marketing Officer. “When considering the distinct needs related to specific chronic and preventive care use cases, the potential impacts quickly become overwhelming. We find time and again that our targeted DCaaS modules help make data actionable in ways that truly resonate with those specific populations.”
Verinovum is a market leader in clinical data curation and enrichment, enabling payers, providers, partners, and OEM organizations to improve operating performance and quality with actionable data. By delivering clean, complete, and accurate data, Verinovum supports healthcare organizations in their efforts to access the right information, in the right format, at the right time, so it may be tailored and curated to fulfill specific use cases and achieve mission-critical clinical and business goals. Discover more at Verinovum.com.